Melamine is widely used as an industrial chemical and has been used in China as an adulterant to increase apparent protein levels in infant formula and other products. An outbreak of melamine-associated pediatric urolithiasis occurred in China in September 2008.[@b1-asm-4-252] Some of these children also experienced kidney damage.[@b2-asm-4-252] Previous studies primarily focused on acute kidney injury caused by the melamine-associated stones, which were mainly localized to the renal interstitium.[@b3-asm-4-252] Recent studies have shown that risk factors for acute kidney injury in infants with melamine-associated urolithiasis are high melamine concentrations in infant formula, age, symptoms of upper respiratory tract infection, diarrhea, dehydration and fever.[@b4-asm-4-252] Epidemiologic investigations have also shown that urolithiasis is an independent factor in the development of chronic kidney disease (CKD).[@b5-asm-4-252] Urinary calculi in animals without acute renal injury can also lead to chronic kidney disease.[@b6-asm-4-252] A similar incident occurred in the United States in 2007 when melamine was used as an adulterant in pet food.[@b7-asm-4-252] Some reports have shown that kidney stones in childhood can herald the future deterioration of renal function and the development of hypertension. [@b8-asm-4-252],[@b9-asm-4-252] However, the long-term and chronic effects of melamine-associated urolithiasis on the kidney are unknown. Our research mainly focused on chronic kidney injury caused by melamine-associated urolithiasis. The preliminary 6-month follow-up study showed that melamine-associated urolithiasis caused kidney tubular and glomerular damage.[@b10-asm-4-252] Furthermore, 30% of the children had not yet discharged their stones. The prognosis and long-term implications of chronic kidney damage in these patients has been unknown. A systematic review of 26 studies also proposed that these patients need for further investigation.[@b11-asm-4-252] This 18-month follow-up study aimed to investigate the long-term prognosis and renal effects in children with melamine-associated urolithiasis.

PATIENTS AND METHODS
====================

From September 17 to October 15, 2008, children (age ≤6 years) with a history of consuming melamine-contaminated milk powder were voluntarily screened at Children's Hospital of Fudan University. The study was approved by the Regional Research Ethics Board, Children's Hospital of Fudan University, China. The patients' guardians or parents provided informed consent for data acquisition.

The diagnostic criteria for melamine-associated urolithiasis were the presence of a definite history of consuming melamine-contaminated milk powder before screening; an absence of urinary system disorders caused by other primary or secondary disease; and an abnormal urinary system by multi-sectional ultrasonography (clump of sharp hyper-echoic foci with or without acoustic shadow in the pelvis, calices of the kidney or ureter, punctiform sharp hyper-echoic foci with "comet-tail" artifacts or acoustic shadow on gray-scale ultrasonography). [@b12-asm-4-252],[@b13-asm-4-252] Ultrasonography was performed using a probe unit of 3.5 to 5 MHz frequency (SEQUOIA 512, Siemens, Germany) in the supine, lateral decubitus, and dorsal positions for each child. Ultrasonographic findings were confirmed by two ultrasonographic physicians. The smallest detectable calculus diameter was 1.0 mm.

After definitive diagnosis, we recorded sex, age, mode of exposure, melamine concentration consumed, duration of exposure, symptoms and findings on physical examination, and results of urinalysis and urinary system ultrasonography for patients diagnosed with melamine-associated urolithiasis. Appropriately therapy was administered immediately upon diagnosis, including encouraging liquid intake, alkalinization of the urine in all patients and hospitalization for patients with severe disease.

Twenty-two types of milk powder were tainted with melamine. Milk powder produced by the Sanlu Group (*<https://www.wikiwand.com/en/Sanlu_Group>*) before August 2008 had the highest melamine concentration, ranging from 162 to 2563 mg/kg. The melamine concentrations of the other brands of milk powder ranged from 0.09 to 150 mg/kg in our screening.[@b14-asm-4-252] We considered Sanlu, Sanlu combined with the other brand(s), and the other brand(s) as high-, middle-, and low-melamine concentration milk powders, respectively.

Children with melamine-associated urolithiasis were followed up at 6 and 18 months after diagnosis. For patients who did not live in Shanghai or were unable to come back to our hospital for subsequent visits, the follow-up was carried out by telephone to record their symptoms. The results of urinalysis and renal ultrasonography were recorded by local physicians. During the two follow-up visits in our hospital, renal and urinary tract ultrasonography were repeated. Creatinine (CR) levels were measured as part of urinary microprotein profiles, including microalbumin (ALBU)/CR (reference range, 0 to 26.5 mg/g), immunoglobulin G (IgG)/CR (reference range, 0 to 14 mg/g), and N-acetyl-β-D-glucosidase (NAG)/CR (reference range, 0.3 to 1.2 U/mmol (based on internal data of Wako Corporation\]).[@b15-asm-4-252],[@b16-asm-4-252] The levels of urinary melamine and cyanuric acid were measured by high performance liquid chromatography-triple quadrupole mass spectrometry (HPLC-MS/MS) at the 18-month follow-up visit.[@b15-asm-4-252]

Statistical analysis
--------------------

Quantitative data are expressed as the mean and standard deviation (SD). A *t* test or one-way analysis of variance (ANOVA) was used as appropriate to compare quantitative data. For patients with two tests of their urinary microprotein profile (n=55), a comparison of the reduction in protein from 6 months to 18 months was analyzed by analysis of covariance (ANCOVA), and the first measured value was used as a covariate. The distribution of each group was expressed as frequencies and percentages. The chi-squared test or Fisher exact test were used as appropriate to analyze categorical data. A logistic regression model was used to analyze factors influencing urinary calculi status (passed or persistent, n=91), and a linear regression model was used to analyze factors influencing the ALBU/CR, IgG/CR and NAG/CR levels (n=78) at 18 months, including sex, age, duration of exposure, size of calculi at initial presentation, and status of calculi during follow-up. A two-tailed *P* value less than 0.05 was considered statistically significant. Statistical analyses were performed using Statistical Package for Social Science (SPSS) version 11.5 and Statistical Analysis Software (SAS) version 9.0.

RESULTS
=======

Of the 8335 screened, 105 (1.3%) were diagnosed with melamine-associated urolithiasis. Three of these children were subsequently excluded from the study ([Figure 1](#f1-asm-4-252){ref-type="fig"}). The causes of loss to follow-up were incorrect addresses and telephone numbers, living in remote areas, and/or unwillingness to return due to working a busy job. Seven patients had surgical removal of calculi within 6--18 months after diagnosis. The initial diameter of the calculi ranged from 1.1 mm to 19.3 mm. A single calculus was found in 65 cases (63.7%), and multiple calculi were found in 37 cases (36.3%).

Of the patients, 77 (75.5%) cases were asymptomatic, and 25 (24.5%) cases showed symptoms such as vomiting, convulsive crying, fever, malaise, and urinary tract infection. Only 1 case (1.0%) presented with acute renal failure and recovered quickly after surgical treatment to remove calculi (ureter retrograde catheterization).

Six months later, 96 children with urolithiasis were followed up (follow-up rate: 91.4%, 62 boys and 34 girls); 18 months after screening, 91 children with urolithiasis were followed up (follow-up rate: 89.2%, 55 boys and 36 girls). Three cases were later found to have unrelated kidney disease and were excluded to avoid bias. The follow-up enrollment and outcome are shown in [Figure 1](#f1-asm-4-252){ref-type="fig"}.

Ultrasonography
---------------

Sixty-five cases (69.9%) passed stones within 6 months, and 82 cases (90.3%) passed stones within 18 months. Of the 12 patients with stones larger than 10 mm, 4 passed their stones spontaneously, 7 underwent surgical removal of their calculi (5 cases: minimally invasive percutaneous nephrolithotomy; 2 cases: placement of ureteral stent), and 1 was lost to follow-up. Nine patients still had calculi after 18 months, but the sizes of the calculi had all decreased. Logistic regression analysis showed that patients with small calculi were more likely to pass the calculi within 18 months (*P*\<.001) ([Table 1](#t1-asm-4-252){ref-type="table"}).

Laboratory analysis of urine
----------------------------

Urinalysis was performed in 82 and 78 children at 6 and 18 months, respectively. The incidence of proteinuria and microscopic hematuria was 6 cases (7.3%) and 14 cases (17.1%) at 6 months and 0 cases (0) and 4 cases (5.1%) at 18 months, respectively. The differences in the incidence rates of proteinuria and microscopic hematuria between the 6-month and 18-month follow-up visits were significant (*P*=.029 and *P*=.017, respectively). Seventy-four patients were tested for the concentration of melamine and cyanuric acid in their urine at 18 months. No melamine or cyanuric acid residue was detected.

Urinary microprotein profiles were separately measured in 76 patients at 6 months and in 78 patients at 18 months. There were significant differences in the proportions of patients with abnormal ALBU/CR and IgG/CR between the two follow-up visits (*P*=.001 and *P*=.018, respectively); The result also showed that the ALBU/CR, IgG/CR and NAG/CR levels in patients at 18 months were significantly lower compared with the levels at the 6 months follow-up (*P*\<.001, *P*=.038 and *P*=.026, respectively) ([Table 2](#t2-asm-4-252){ref-type="table"}). Linear regression showed that at 18 months, high levels of ALBU/CR were primarily associated with younger age (−1.778; 95% confidence interval \[CI\], −3.338 to −0.218; *P*=.026) and high melamine concentration consumed (−1.528; 95% CI, −2.779 to −0.277; *P*=.018); high IgG/CR was primarily associated with a high melamine concentration consumed (−1.435; 95% CI, −2.468 to −0.402; *P*=.007) and size of calculi (1.658; 95% CI, 0.231 to 3.140; *P*=.024); and NAG/CR might have been related to the high melamine concentration consumed (−0.130; 95% CI, −0.273 to 0.012; *P*=.072) ([Table 3](#t3-asm-4-252){ref-type="table"}).

Fifty-five patients had urinary microprotein profiles at both 6 and 18 months. IgG/CR and NA/CR after 18 months was significantly decreased compared with that after 6 months ([Figure 2](#f2-asm-4-252){ref-type="fig"}). We analyzed the extent of the reduction in urinary microprotein from 6 to 18 months between children with persistent stones and children who passed their calculi. The reduction in NAG/CR in children who passed calculi was significantly higher than in children with persistent calculi at 6 or 18 months (*P*=.019 and *P*=.041, respectively). The reduction of ALBU/CR in children who passed calculi was significantly higher than in children with persistent calculi at 18 months (*P*\<.001), which was not observed in our previous study. We also analyzed the urinary microprotein profile between children who passed calculi within 6 months and children who passed calculi after 6 to 18 months. The reduction in NAG/CR and IgG/CR in children who passed calculi within 6 months was higher than in children who passed calculi after 6 but before 18 months, indicating that earlier passage might aid in recovery from renal injury ([Table 4](#t4-asm-4-252){ref-type="table"}).

DISCUSSION
==========

The combination of melamine and cyanuric acid can produce renal toxicity due to significant chemical accumulation in the kidney accompanied by low excretion.[@b16-asm-4-252] The long-term prognosis and chronic effects on the kidney of melamine-associated urolithiasis are the main concerns in our long-term follow-up study. After 18 months, the vast majority of the patients had passed their calculi. Therefore, for most patients with melamine-associated urolithiasis, conservative treatment was effective and had a lower risk of adverse effects. For patients with large urinary calculi (≥10 mm), our findings showed that most of the calculi were not passed even after 18 months. For these patients, surgical intervention should be considered as early as possible.

It has been reported that the urinary melamine levels of children with melamine-associated calculi were significantly increased in the acute stage.[@b17-asm-4-252] However, it was still unknown whether the body retains melamine in the long term. In our study, we found that the urine melamine and cyanuric acid levels of all of the patients were normal. Moreover, no patient formed new calculi or had a recurrence during follow-up. It is important for these children to stop the intake of melamine.

After 18 months, the incidence rates of proteinuria and microscopic hematuria and the levels of ALBU/CR, IgG/CR and NAG/CR were all significantly reduced. However, 20.8% of these children still had abnormal urinary microprotein profiles; the main abnormal factors were the concentration of melamine consumed, the size of the calculi and the age of the patient. The consumption of higher concentrations of melamine can lead to a slower recovery from renal injury.

To assess the effects of melamine-associated stones on recovery from renal injury, we analyzed the extent of changes in the urinary microprotein profiles between 6 and 18 months. We found that the presence of long-term persistent calculi can result in chronic glomerular injury, which was not observed in our previous 6-month follow-up study.[@b10-asm-4-252] The children who passed their calculi recovered from renal tubular injury more quickly than children who had not passed their calculi. Moreover, the reduction in IgG/CR and NAG/CR was greater for patients who passed their calculi within 6 months compared with patients who passed their calculi after 6 months. These results indicate that passage of the melamine-associated calculus was an important factor for recovery from renal tubular injury.

Our study has certain limitations. Our hospital is thought to attract more patients than other hospitals and as a result, selection bias might have increased the rate of diagnosis. There may have been more visits to our hospital than other hospitals or patients may have come to our hospital after diagnosis at other hospitals. We also could not completely exclude confounding bias caused by non-melamine-related renal stones.

Over 18 months of follow-up, we discovered that most patients with melamine-associated calculi can pass their calculi spontaneously. Long-term persistent calculi can result in chronic glomerular injury that recovers slowly. Earlier passage of calculi is associated with a more rapid recovery from renal injury.
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###### 

Logistic regression analysis of patient factors influencing the passage of calculi at 18 months after initial presentation (n=91).

  Characteristics                          Persistent stones, n (%)   Passed stone, n (%)   Odds ratio (95% CI)       *P*
  ---------------------------------------- -------------------------- --------------------- ------------------------- --------
  **Sex**                                                                                                             
  Male                                     3 (5.5)                    52 (94.5)             5.401 (0.971--31.811)     .062
  Female                                   6 (16.7)                   30 (83.3)             1.0                       
  **Age (months)**                                                                                                    
  0 to ≤12                                 1 (2.9)                    33 (97.1)             22.206 (0.874--546.488)   .060
  \>12 to ≤36                              2 (6.9)                    27 (93.1)             3.054 (0.423--21.879)     .269
  \>36 to ≤72                              6 (21.4)                   22 (78.6)             1.0                       
  **Duration of exposure (months)**                                                                                   
  ≤6                                       1 (9.1)                    30 (90.9)             0.519 (0.044--6.115)      .602
  6--12                                    3 (5.9)                    32 (94.1)             2.959 (0.332--26.407)     .331
  \>12                                     5 (16.7)                   20 (83.3)             1.0                       
  **Concentration of melamine consumed**                                                                              
  High                                     7 (14.3)                   42 (85.7)             0.154 (0.014--1.643)      .121
  Middle                                   1 (11.1)                   11 (91.7)             0.562 (0.016--20.315)     .753
  Low                                      1 (11.1)                   29 (96.7)             1.0                       
  **Diameter of calculi (mm)**                                                                                        
  ≤5                                       6 (6.6)                    60 (90.9)             5.838 (4.259--8.000)      \<.001
  \>5 to ≤10                               3 (3.3)                    11 (78.6)             1.0                       
  \>10                                     0 (0)\*                    11 (100.0)                                      

###### 

Comparison of urinary microprotein profiles at 6 and 18 months of follow-up.

  Urinary microprotein profiles   First follow-up (6 mo), n=76   Second follow-up (18 mo), n=77   *P*         
  ------------------------------- ------------------------------ -------------------------------- ----------- ------
  ALBU/CR                         Abnormal number, n (%)         21 (27.6)                        5 (6.4)     .001
  Value (mg/g)                    26.06 (17.78)                  13.64 (3.65)                     \<.001      
  IgG/CR                          Abnormal number, n (%)         13 (17.1)                        4 (5.1)     .018
  Value (mg/g)                    15.9 (10.53)                   9.63 (2.30)                      .038        
  NAG/CR                          Abnormal number, n (%)         16 (21.1)                        10 (12.8)   .173
  Value (u/mmol)                  0.92 (0.34)                    0.66 (0.32)                      .026        

Values are mean (standard deviation).

###### 

Linear regression analysis of factors influencing urinary microprotein profiles at 18 months after initial presentation.[\*](#tfn2-asm-4-252){ref-type="table-fn"}

                   Factors                              B                95% CI           *P*                                              R^2^
  ---------------- ------------------------------------ ---------------- ---------------- ------------------------------------------------ -------
  ALBU/CR          Concentration of melamine consumed   −1.528           −2.779--−0.277   .018                                             0.213
  Age              −1.778                               −3.338--−0.218   .026                                                              
  IgG/CR           Concentration of melamine consumed   −1.435           −2.468--−0.402   .007                                             0.144
  Size of stones   1.685                                0.231--3.140     .024                                                              
  NAG/CR           Concentration of melamine consumed   −0.130           −0.273--0.012    .072[\*](#tfn2-asm-4-252){ref-type="table-fn"}   0.100

The table only shows the statistically significant independent factors for the three dependent variables. Other independent variables included sex, age, duration of exposure, size of calculi at initial presentation, and status of calculi during follow-up.

###### 

Comparison of the reduction[a](#tfn3-asm-4-252){ref-type="table-fn"} in urinary microprotein from 6 to 18 months between patients with and without persistent stones by ANCOVA.[b](#tfn4-asm-4-252){ref-type="table-fn"}

                                       Status of calculi      ALBU/CR         IgG/CR         NAG/CR                             
  ------------------------------------ ---------------------- --------------- -------------- ------------- ------ ------------- ------
  First follow-up (6 months)           Passed stones (n=40)   10.45 (21.23)   .387           0.25 (0.66)   .086   0.39 (0.52)   .019
  Persistent stones (n=15)             14.25 (22.07)          0.06 (0.52)     0.05 (0.57)                                       
  Second follow-up (18 months)         Passed stones (n=48)   7.68 (13.00)    \<.001         0.24 (0.66)   .225   0.36 (0.55)   .041
  Persistent stones (n=7)              4.44 (4.98)            −0.03 (0.23)    −0.13 (0.41)                                      
  Within 6 months (n=39)               Passed stones          4.53 (5.47)     .506           0.25 (0.67)   .276   0.38 (0.55)   .120
  After 6 but before 18 months (n=6)   4.95 (9.96)            −0.05 (0.35)    0.012 (0.35)                                      

The mean of the second follow-up minus the mean of the first follow-up.

ANCOVA was used to eliminate the impact of the first follow-up measures on the extent of reduction.
